Could a single IV dose and brain training offer new hope for depression?
Disease control
Recruiting now
This study is testing a new, fast-acting medication called apimostinel for treating major depression. Researchers want to see if it works better than a placebo and if adding a digital brain training program helps the benefits last longer. The trial will involve 150 adults with de…
Phase: PHASE2 • Sponsor: Rebecca Price • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC